Optimal Lipid Modification: The Rationale for Combination Therapy

BACKGROUND: An emphasis on more aggressive lipid-lowering, particularly of low-density lipoprotein cholesterol, to improve patient outcomes has led to an increased use of combination lipid-lowering drugs. This strategy, while potentially beneficial, has triggered concerns regarding fears of adverse...

Descripción completa

Detalles Bibliográficos
Autores principales: Backes, James M, Gibson, Cheryl A, Howard, Patricia A
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2005
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1993967/
https://www.ncbi.nlm.nih.gov/pubmed/17315604

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1993967/
https://www.ncbi.nlm.nih.gov/pubmed/17315604

Ejemplares similares